Free Trial

Eagle Pharmaceuticals (EGRX) Competitors

Eagle Pharmaceuticals logo
$3.55 -0.10 (-2.74%)
As of 02:50 PM Eastern

EGRX vs. BIOA, CGEN, ALEC, GALT, ACOG, IKT, ALTS, KYTX, RAPT, and LXEO

Should you be buying Eagle Pharmaceuticals stock or one of its competitors? The main competitors of Eagle Pharmaceuticals include BioAge Labs (BIOA), Compugen (CGEN), Alector (ALEC), Galectin Therapeutics (GALT), Alpha Cognition (ACOG), Inhibikase Therapeutics (IKT), ALT5 Sigma (ALTS), Kyverna Therapeutics (KYTX), Rapt Therapeutics (RAPT), and Lexeo Therapeutics (LXEO). These companies are all part of the "pharmaceutical products" industry.

Eagle Pharmaceuticals vs. Its Competitors

Eagle Pharmaceuticals (NASDAQ:EGRX) and BioAge Labs (NASDAQ:BIOA) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

In the previous week, Eagle Pharmaceuticals and Eagle Pharmaceuticals both had 1 articles in the media. Eagle Pharmaceuticals' average media sentiment score of 0.00 equaled BioAge Labs'average media sentiment score.

Company Overall Sentiment
Eagle Pharmaceuticals Neutral
BioAge Labs Neutral

85.4% of Eagle Pharmaceuticals shares are owned by institutional investors. 28.9% of Eagle Pharmaceuticals shares are owned by company insiders. Comparatively, 20.8% of BioAge Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Eagle Pharmaceuticals has higher revenue and earnings than BioAge Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eagle Pharmaceuticals$257.55M0.18$35.64MN/AN/A
BioAge LabsN/AN/A-$71.11MN/AN/A

Company Net Margins Return on Equity Return on Assets
Eagle PharmaceuticalsN/A N/A N/A
BioAge Labs N/A N/A N/A

Summary

Eagle Pharmaceuticals beats BioAge Labs on 4 of the 4 factors compared between the two stocks.

Get Eagle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EGRX vs. The Competition

MetricEagle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$46.10M$799.38M$5.57B$9.02B
Dividend YieldN/A4.84%5.25%4.03%
P/E RatioN/A1.3027.1820.14
Price / Sales0.18227.16417.49184.08
Price / Cash0.4023.4437.0657.97
Price / BookN/A6.178.085.60
Net Income$35.64M-$27.58M$3.16B$248.50M
7 Day Performance18.33%2.12%3.77%5.15%
1 Month Performance69.05%8.39%3.90%7.62%
1 Year Performance-41.23%8.05%34.22%21.56%

Eagle Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EGRX
Eagle Pharmaceuticals
2.5847 of 5 stars
$3.55
-2.7%
N/A-39.9%$46.10M$257.55M0.00100News Coverage
Gap Down
BIOA
BioAge Labs
N/A$4.13
-1.7%
N/AN/A$150.57MN/A0.00N/ANews Coverage
CGEN
Compugen
1.4067 of 5 stars
$1.78
+7.2%
$4.00
+124.7%
-5.1%$148.13M$27.86M-11.1370Positive News
ALEC
Alector
4.0712 of 5 stars
$1.40
-5.4%
$4.00
+185.7%
-65.4%$147.99M$100.56M-1.11270News Coverage
GALT
Galectin Therapeutics
1.4075 of 5 stars
$2.11
-9.4%
$6.00
+184.4%
-5.1%$147.47MN/A-2.939News Coverage
Gap Up
ACOG
Alpha Cognition
1.5021 of 5 stars
$9.33
+2.5%
$20.00
+114.4%
N/A$145.86MN/A-7.77N/A
IKT
Inhibikase Therapeutics
1.2368 of 5 stars
$1.95
+20.4%
$6.50
+233.3%
+51.2%$144.97M$260K-0.736
ALTS
ALT5 Sigma
0.0642 of 5 stars
$7.24
-10.9%
N/AN/A$141.91M$12.53M0.00170
KYTX
Kyverna Therapeutics
1.7191 of 5 stars
$3.07
-6.4%
$18.50
+502.6%
-62.2%$141.76M$7.03M-0.9196News Coverage
Positive News
RAPT
Rapt Therapeutics
4.287 of 5 stars
$8.00
-5.1%
$24.00
+200.0%
-67.2%$139.40M$1.53M-0.4280Analyst Forecast
LXEO
Lexeo Therapeutics
2.2836 of 5 stars
$4.02
-2.4%
$16.60
+312.9%
-72.5%$136.77M$650K-1.2258

Related Companies and Tools


This page (NASDAQ:EGRX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners